GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Blue Jet Healthcare Ltd

Blue Jet Healthcare Q2 FY27 Standalone Net Profit Up to INR 1,025.17 million

RESULTS ▲ Positive Development LOW RISK
📅 Filed on BSE: 05 Nov 2026, 12:49 PM IST  ·  BSE ID: 21ac6c03-664a-4c7d-9f2f-fa9024e8ec3d
View Original BSE Filing (PDF)
💡
In Simple Terms
Blue Jet Healthcare reported strong Q2 FY27 financial results and raised INR 8,000.00 million through a share sale.
🤖 AI Summary
  • Blue Jet Healthcare Board approved unaudited standalone financial results for Q2 FY27 and H1 FY27.
  • Q2 FY27 Revenue from Operations was INR 3,757.44 million, up from INR 1,654.81 million in Q2 FY26.
  • Net Profit for Q2 FY27 reached INR 1,025.17 million, compared to INR 521.36 million in Q2 FY26.
  • Company completed a Qualified Institutional Placement (QIP) during Q2 FY27, raising INR 8,000.00 million.
  • Total Assets as of September 30, 2026, increased to INR 25,838.78 million from INR 16,411.58 million as of March 31, 2026.
🔢 Key Numbers - exact figures from BSE filing, not rounded
Revenue from Operations (Q2 FY27)
3,757.44 million
127.07%
Profit for the period (Net Profit) (Q2 FY27)
1,025.17 million
96.61%
Basic EPS (Q2 FY27)
5.46
81.39%
QIP Proceeds
8,000.00 million
Total Assets (Sep 30, 2026)
25,838.78 million
Cash and Cash Equivalents (Sep 30, 2026)
767.27 million
🏢 How This Affects the Company
📈
Business Impact
Revenue from operations for Q2 FY27 showed a substantial increase, indicating growth in its manufacturing segments of Artificial Sweetener, Contrast Media Intermediate, Pharma Intermediate, and APIs.
💰
Financial Impact
The Qualified Institutional Placement (QIP) of INR 8,000.00 million significantly increased Equity Share Capital and Other Equity, strengthening the balance sheet and improving liquidity. Total Assets expanded by INR 9,427.20 million.
⚠️
Risk Impact
The QIP proceeds provide capital for potential future expansion or operational needs, potentially reducing reliance on debt financing.
👥 What This Means For Shareholders
✅
Action Required
No action required from shareholders based on this financial results filing.
👤
Who Is Affected
All existing shareholders are affected by the dilution resulting from the Qualified Institutional Placement (QIP) of 1,58,10,276 new equity shares.
🔍
Management Signal
Management is focused on increasing capital base and scaling operations, as evidenced by the successful QIP and strong revenue growth.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Q3 FY27 results — monitor revenue and profit growth trends.
Utilization of QIP proceeds — track any specific announcements on fund deployment.
Operating cash flow trends — observe improvement in subsequent periods.
LOW RISK The filing indicates strong financial performance and a significant capital infusion, mitigating short-term financial risks.
💡 Investor Takeaway
Blue Jet Healthcare reported Q2 FY27 Revenue from Operations of INR 3,757.44 million, a 127.07% increase YoY. Net Profit for the period was INR 1,025.17 million, up 96.61% YoY. The company successfully raised INR 8,000.00 million through a Qualified Institutional Placement during Q2 FY27.
⚖️ Strengths & Concerns

✅ Positives

  • Revenue from Operations for Q2 FY27 was INR 3,757.44 million, demonstrating a 127.07% increase YoY.
  • Profit for the period (Net Profit) for Q2 FY27 stood at INR 1,025.17 million, up 96.61% YoY from INR 521.36 million.

⚠️ Concerns

  • Cash used in Operating Activities for H1 FY27 was (INR 256.12) million, a decrease from INR 2,071.87 million in H1 FY26.
  • Trade Receivables increased to INR 4,446.52 million as of September 30, 2026, from INR 3,390.46 million as of March 31, 2026.
📅 Company Track Record
Blue Jet Healthcare reported audited standalone financial statements for FY26 in July 2026. The company also announced a board meeting in July 2026 for Q1 FY27 results, indicating regular financial reporting. This current filing details the Q2 FY27 and H1 FY27 performance.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What was Blue Jet Healthcare's Revenue from Operations for Q2 FY27?
Blue Jet Healthcare reported Revenue from Operations of INR 3,757.44 million for the quarter ended September 30, 2026 (Q2 FY27).
What was Blue Jet Healthcare's Net Profit in Q2 FY27?
The Profit for the period (Net Profit) for Blue Jet Healthcare in Q2 FY27 was INR 1,025.17 million, compared to INR 521.36 million in Q2 FY26.
How much capital did Blue Jet Healthcare raise via QIP during Q2 FY27?
Blue Jet Healthcare raised INR 8,000.00 million during Q2 FY27 through a Qualified Institutional Placement by allotting 1,58,10,276 equity shares at INR 506 per share.
What were Blue Jet Healthcare's total assets as of September 30, 2026?
As of September 30, 2026, Blue Jet Healthcare's total assets stood at INR 25,838.78 million, an increase from INR 16,411.58 million as of March 31, 2026.
What was Blue Jet Healthcare's Basic Earnings per Share (EPS) for Q2 FY27?
Blue Jet Healthcare's Basic Earnings per Share (EPS) for Q2 FY27 was 5.46 per share, up from 3.01 per share in Q2 FY26.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.